For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the ...

In the Phase 2 MINDFuL trial of XProTM in patients with early Alzheimer's Disease (AD) with biomarkers of inflammation, the modified intent-to-treat ...

I remember the first time I was on stage and scrambled my words. If my lines in a play were supposed to be "Sherwin-Williams, ...

The primary endpoint was change in cognition over 6 months on the Early Mild Alzheimer’s Cognitive Composite (EMACC), a cognitive assessment designed specifically to measure change in early AD ...